OLEMA PHARMACEUTICALS INC's ticker is OLMA and the CUSIP is 68062P106. A total of 78 filers reported holding OLEMA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,628,249 | +30.9% | 131,842 | -4.3% | 0.00% | +33.3% |
| Q2 2023 | $1,243,467 | +122.0% | 137,704 | -14.7% | 0.00% | +50.0% |
| Q1 2023 | $560,173 | +24.1% | 161,433 | -12.4% | 0.00% | +100.0% |
| Q4 2022 | $451,466 | -44.0% | 184,272 | -36.9% | 0.00% | -66.7% |
| Q3 2022 | $806,000 | -37.6% | 291,970 | -7.9% | 0.00% | -25.0% |
| Q2 2022 | $1,291,000 | -49.0% | 317,156 | -46.6% | 0.00% | -42.9% |
| Q1 2022 | $2,532,000 | -56.7% | 594,343 | -4.8% | 0.01% | -41.7% |
| Q4 2021 | $5,843,000 | +113.1% | 624,300 | +527.4% | 0.01% | +100.0% |
| Q3 2021 | $2,742,000 | – | 99,500 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Logos Global Management LP | 3,743,875 | $15,238,000 | 2.80% |
| Fairmount Funds Management LLC | 2,669,300 | $10,864,000 | 2.49% |
| BVF INC/IL | 7,611,503 | $30,979,000 | 1.50% |
| Vivo Capital, LLC | 1,689,515 | $6,876,000 | 0.69% |
| Cormorant Asset Management, LP | 2,082,000 | $8,474,000 | 0.64% |
| Newtyn Management, LLC | 500,000 | $2,035,000 | 0.39% |
| Kynam Capital Management, LP | 249,229 | $1,014,000 | 0.26% |
| Monaco Asset Management SAM | 130,000 | $529,000 | 0.23% |
| TANG CAPITAL MANAGEMENT LLC | 318,926 | $1,298,000 | 0.20% |
| Artal Group S.A. | 260,500 | $1,060,000 | 0.06% |